These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Reversible severe anaemia and granulocytopenia caused by procainamide. A case report. van Beek RJ; Bieger R; den Ottolander GJ Scand J Haematol; 1978 Aug; 21(2):150-2. PubMed ID: 694426 [TBL] [Abstract][Full Text] [Related]
29. Comparative bioequivalence and efficacy of two sustained-release procainamide formulations in patients with cardiac arrhythmias. Hilleman DE; Patterson AJ; Mohiuddin SM; Ortmeier BG; Destache CJ Drug Intell Clin Pharm; 1988; 22(7-8):554-8. PubMed ID: 2458219 [TBL] [Abstract][Full Text] [Related]
30. Procainamide-induced agranulocytosis: report of two cases and review. Nagesh KG; Poulose KP; Tseng TH; Schadchehr A J Kans Med Soc; 1980 Jan; 81(1):18-24. PubMed ID: 6153211 [No Abstract] [Full Text] [Related]
31. Sustained-release procainamide: use of serum concentrations to determine dosage. Reed WE; Cooper MW South Med J; 1985 Oct; 78(10):1190-3. PubMed ID: 4049036 [TBL] [Abstract][Full Text] [Related]
33. A pharmacokinetic comparison of two sustained-release oral procainamide preparations. Hore P; Bones P; Rollinson T; Ikram H Br J Clin Pharmacol; 1979 Sep; 8(3):267-71. PubMed ID: 497093 [TBL] [Abstract][Full Text] [Related]
34. [Agranulocytosis caused by procainamide (Pronestyl)]. Hensen A Ned Tijdschr Geneeskd; 1974 Apr; 118(17):624-5. PubMed ID: 4133296 [No Abstract] [Full Text] [Related]
35. Antiarrhythmic and hemodynamic evaluation of indecainide and procainamide in nonsustained ventricular tachycardia. Pratt CM; Francis MJ; Seals AA; Zoghbi W; Young JB Am J Cardiol; 1990 Jul; 66(1):68-74. PubMed ID: 2193498 [TBL] [Abstract][Full Text] [Related]
36. [Procainamide induced agranulocytosis]. Rollag A Tidsskr Nor Laegeforen; 1982 Jan; 102(2):96-7. PubMed ID: 7101253 [No Abstract] [Full Text] [Related]
37. Agranulocytosis, procainamide, and phenytoin. Fleet S Ann Intern Med; 1984 Apr; 100(4):616-7. PubMed ID: 6703561 [No Abstract] [Full Text] [Related]
38. Septic complications of procainamide-induced agranulocytosis: report of two cases. Freed JS; Reiner MA Mt Sinai J Med; 1988 Mar; 55(2):194-7. PubMed ID: 3290673 [No Abstract] [Full Text] [Related]
39. Efficacy of a new sustained release procainamide preparation: evaluation with 24-hour Holter monitoring. Garcia JR; Godley ML; Freedman RJ J La State Med Soc; 1982; 134(1):8-9. PubMed ID: 7086265 [No Abstract] [Full Text] [Related]
40. Desensitization to procainamide. Ream CR; Barrera R J Med Soc N J; 1970 Mar; 67(3):107-10. PubMed ID: 5264623 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]